loading page

Whole Exome Sequencing Identifies a Novel Pathogenic BMPR2 Variant in Pulmonary Atresia
  • +3
  • Muyu Qi,
  • Xiaoping Lan,
  • Rufang Zhang,
  • Jia Li,
  • Junwen Ge,
  • Li Shen
Muyu Qi
Shanghai Children's Hospital

Corresponding Author:[email protected]

Author Profile
Xiaoping Lan
Shanghai Children's Hospital
Author Profile
Rufang Zhang
Shanghai Children's Hospital
Author Profile
Jia Li
Shanghai Children's Hospital
Author Profile
Junwen Ge
Shanghai Children's Hospital
Author Profile
Li Shen
Shanghai Children's Hospital
Author Profile

Abstract

Objective Pulmonary atresia (PA) is a rare type of complex cyanotic congenital heart defect mainly characterized by an undeveloped pulmonary valve or pulmonary artery. herefore, defining a disease-causing gene mutation in a pulmonary atresia family becomes a possible method of the genetic counseling, future prenatal diagnosis, and therapeutic approaches of pulmonary atresia. Methods Blood samples of six members in a PA family were collected, and the genomic DNA was extracted using the QIAamp DNA Blood Mini Kit. The gene detection was performed using the second-generation sequencing gene Panel. Results Genetic testing results indicates as follows: A heterozygous mutation originated from maternal inheritance was detected in the BMPR2 gene of the proband’s genomic DNA. The pathogenic gene was at c.2804C>T (p. A935V). The mutation was also detected in the genomic DNA of the proband’s elder brother(III-1), but not in other family members. Conclusion To our knowledge, this is the first study to report the BMPR2 variant responsible for pulmonary atresia. The frequency of c.2804C>T (p. A935V) mutation detected in this family is extremely low in the normal population (1/ 246048). The mutation was highly conservative in different species. And SIFT (sorting intorlerant from tolerant) predicts it to be a harmful mutation.